Lactate in cystic fibrosis sputum

Slides:



Advertisements
Similar presentations
Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis  Michael W. Konstan, Felix Ratjen 
Advertisements

Alveolar inflammation in cystic fibrosis
Effects of ivacaftor on severely ill patients with cystic fibrosis carrying a G551D mutation  Helge Hebestreit, Annette Sauer-Heilborn, Rainald Fischer,
Rapid emergence of a ceftazidime-resistant Burkholderia multivorans strain in a Cystic Fibrosis patient  Joshua R. Stokell, Raad Z. Gharaibeh, Todd R.
Achromobacter species in cystic fibrosis: Cross-infection caused by indirect patient-to- patient contact  C.R. Hansen, T. Pressler, W. Ridderberg, H.K.
Christopher C. Miller, Christopher A
BIIL 284 reduces neutrophil numbers but increases P
Dietary supplementation with multiple micronutrients: No beneficial effects in pediatric cystic fibrosis patients  Johanna H. Oudshoorn, Peter H.C. Klijn,
Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients  Yvonne C.W. Yau, Felix Ratjen, Elizabeth Tullis,
William G. Flight, Jonathan Shaw, Susan Johnson, A
Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection—A.
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
H. Grasemann, E. Tullis, F. Ratjen  Journal of Cystic Fibrosis 
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
D. Worlitzsch, C. Rintelen, K. Böhm, B. Wollschläger, N. Merkel, M
Laura Viviani, Baroukh M. Assael, Eitan Kerem 
Raphaël Chiron, Y. Yaël Grumbach, Nga V. T
A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study  Maret L. Maliniak, Arlene A.
Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin 
John Widger, Sarath Ranganathan, Philip J. Robinson 
Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection  Marita Gilljam, Henrik Scherstén, Martin Silverborn, Bodil.
The ease of breathing test tracks clinical changes in cystic fibrosis
Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis  T.W.V. Daniels, G.B. Rogers, F.A. Stressmann, C.J.
Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia  P.Ø. Jensen, C. Moser, A. Kharazmi,
Pulmonary exacerbations in CF patients with early lung disease
A cohort study of the Copenhagen CF Centre eradication strategy against Staphylococcus aureus in patients with CF  Christina Schjellerup Dalbøge, Tacjana.
Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study  Christine Rønne.
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Gerd Döring, Patrick Flume, Harry Heijerman, J. Stuart Elborn 
Vitamin A and lung function in CF
Pulmonary nocardiosis in cystic fibrosis
A.H. Gifford  Journal of Cystic Fibrosis 
Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis  Elizabeth F. Shead, Charles S. Haworth,
Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden  Per Kristian Knudsen, Hanne.
Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009  Yolanda P. Lillquist,
Physiologic endpoints for clinical studies for cystic fibrosis
Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis  D.W. Reid, R. Latham, I.L.
Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis 
Low sodium status in cystic fibrosis—as assessed by calculating fractional Na+ excretion—is associated with decreased growth parameters  Christiane Knepper,
Valerie Waters, Eshetu G
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Sally H. Pattison, Geraint B. Rogers, Martin Crockard, J
Nasal polyposis in lung transplant recipients with cystic fibrosis
Pharmacokinetics and sputum penetration of azithromycin during once weekly dosing in cystic fibrosis patients  E.B. Wilms, D.J. Touw, H.G.M. Heijerman 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic  Amanda L. Griffiths, Danielle F. Wurzel,
Theresa A. Laguna, Cynthia B. Williams, Kyle R
Nutritional decline in cystic fibrosis related diabetes: The effect of intensive nutritional intervention  H. White, K. Pollard, C. Etherington, I. Clifton,
Alina A. Ionescu, Lisette S. Nixon, Dennis J. Shale 
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
James H. Hull, Rachel Garrod, Timothy B. Ho, Ronald K. Knight, John R
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis  Hanne Vebert Olesen, Uffe Holmskov, Peter Oluf Schiøtz, Grith Lykke Sørensen 
C. R. Hansen, T. Pressler, K. G. Nielsen, P. Ø. Jensen, T
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation  C. Etherington,
CFTR modulators and pregnancy: Our work has only just begun
Airway inflammation in mild cystic fibrosis
Treatment intensity and characteristics of MRSA infection in CF
Patients with cystic fibrosis and normoglycemia exhibit diabetic glucose tolerance during pulmonary exacerbation  Noa Nezer M. Sc, David Shoseyov, Eitan.
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Cystic fibrosis and pregnancy in the modern era: A case control study
R. D. Gray, M. Imrie, A. C. Boyd, D. Porteous, J. A. Innes, A. P
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience  C.R.
Presentation transcript:

Lactate in cystic fibrosis sputum Tobias Bensel, Martin Stotz, Marianne Borneff-Lipp, Bettina Wollschläger, Andreas Wienke, Giovanni Taccetti, Silvia Campana, Keith C. Meyer, Peter Ø. Jensen, Ute Lechner, Martina Ulrich, Gerd Döring, Dieter Worlitzsch  Journal of Cystic Fibrosis  Volume 10, Issue 1, Pages 37-44 (January 2011) DOI: 10.1016/j.jcf.2010.09.004 Copyright © 2010 European Cystic Fibrosis Society Terms and Conditions

Fig. 1 Individual (•) and mean (■) lactate concentrations in sputum of 18 CF patients before (pre) and after (post) i.v. antibiotic treatment because of exacerbations decrease significantly (A, p=0.0043), whereas FVC simultaneously increases (B, p=0.13). Journal of Cystic Fibrosis 2011 10, 37-44DOI: (10.1016/j.jcf.2010.09.004) Copyright © 2010 European Cystic Fibrosis Society Terms and Conditions

Fig. 2 In sputum of stable CF patients (n=25), lactate and lung function correlate negatively (r=−0.446). Journal of Cystic Fibrosis 2011 10, 37-44DOI: (10.1016/j.jcf.2010.09.004) Copyright © 2010 European Cystic Fibrosis Society Terms and Conditions

Fig. 3 Human neutrophils [5×106cells/mL] incubated aerobically (+O2) or anaerobically (−O2) for 4h, produced more lactate during anaerobiosis if freeze-cracked (#) or not. Journal of Cystic Fibrosis 2011 10, 37-44DOI: (10.1016/j.jcf.2010.09.004) Copyright © 2010 European Cystic Fibrosis Society Terms and Conditions

Fig. 4 Lactate production by human neutrophils [1×107cells/mL] grown aerobically (■) and anaerobically (□) for up to 4days. Journal of Cystic Fibrosis 2011 10, 37-44DOI: (10.1016/j.jcf.2010.09.004) Copyright © 2010 European Cystic Fibrosis Society Terms and Conditions

Fig. 5 High correlation (r=0.8386) between lactate concentration and lactate dehydrogenase (LDH) activity in CF sputum samples (n=29). Journal of Cystic Fibrosis 2011 10, 37-44DOI: (10.1016/j.jcf.2010.09.004) Copyright © 2010 European Cystic Fibrosis Society Terms and Conditions

Fig. 6 In sputum with an oxygen gradient (dark green: +O2, light green: −O2) inside the airways of CF patients with stable chronic lung infection and inflammation (A), neutrophils and bacterial microcolonies exist at equilibrium. Planctonic bacteria in the +O2 layer are killed effectively. Sputum lactate concentrations (L) and forced expiratory volume in 1s (FEV1) are in steady-state. During exacerbations (B), the balance is destabilized, additional neutrophils arise, extensive sputum production occurs, FEV1 decreases, and lactate concentration increases. When antibiotic or antiinflammatory treatment is successful (C), neutrophils phagocytose the remaining bacteria, the surplus sputum may be coughed out, and FEV1 and lactate concentrations begin to normalize. At the end of an exacerbation (D), the status quo ante is reached again, and lactate as well as FEV1 return to initial values. Journal of Cystic Fibrosis 2011 10, 37-44DOI: (10.1016/j.jcf.2010.09.004) Copyright © 2010 European Cystic Fibrosis Society Terms and Conditions